Biotinylated Human B7-1 / CD80 Protein, Avitag™,His Tag (recommended for biopanning) (MALS verified)

Customer Reviews
Cat. No. / Size
Price
Qty
B71-H82E9-25ug
$360.00
B71-H82E9-200ug
$1420.00
ETA of in-stock products:2 business days

Product Details

  • Synonym

    CD80, B7, B7-1, B7.1, BB1, CD28LG, CD28LG1, LAB7

  • Source

    Biotinylated Human B7-1 Protein, Avitag,His Tag (B71-H82E9) is expressed from human 293 cells (HEK293). It contains AA Val 35 - Asn 242 (Accession # P33681-1).

    Predicted N-terminus: Val 35

    Request for sequence
  • Molecular Characterization

    B7-1 Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries an Avi tag (Avitag™) at the C-terminus, followed by a polyhistidine tag.

    The protein has a calculated MW of 26.5 kDa. The protein migrates as 44-54 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Labeling

    Biotinylation of this product is performed using Avitag™ technology. Briefly, the single lysine residue in the Avitag is enzymatically labeled with biotin.

  • Protein Ratio

    Passed as determined by the HABA assay / binding ELISA.

  • Application

    B71-H82E9 works best for experiments that test the binding between B7-1 and candidate antibodies, such as biopanning and other relevant assays.

  • Purity

    >95% as determined by SDS-PAGE.

    >95% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    B7-1 SDS-PAGE

    Biotinylated Human B7-1 Protein, Avitag,His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).

  • SEC-MALS

    B7-1 SEC-MALS

    The purity of Biotinylated Human B7-1 Protein, Avitag,His Tag (Cat. No. B71-H82E9) is more than 95% and the molecular weight of this protein is around 35-55 kDa verified by SEC-MALS.

    Report
  • Bioactivity-ELISA

     B7-1 ELISA

    Immobilized Anti-CD80 MAb, Human IgG1 at 5 μg/mL (100 μL/well) can bind Biotinylated Human B7-1 Protein, Avitag,His Tag (Cat. No. B71-H82E9) with a linear range of 0.1-3 ng/mL (QC tested).

    Protocol

Customer Reviews
Writing Reviews

Background

B7-1 and B7-2, together with their receptors CD28 and CTLA­4, constitute one of the dominant co-stimulatory pathways that regulate T­ and B­cell responses. Although both CTLA­4 and CD28 can bind to the same ligands, CTLA­4 binds to B7­1 and B7­2 with a 20 ­ 100 fold higher affinity than CD28 and is involved in the down­regulation of the immune response.
B-lymphocyte activation antigen B7-1 (referred to as B7) also known as cluster of Differentiation 80 (CD80), is a member of cell surface immunoglobulin superfamily and is expressed on activated B cells, activated T cells, macrophages and dendritic cells. It is the ligand for two different proteins on the T cell surface: CD28 (for autoregulation and intercellular association) and CTLA-4 (for attenuation of regulation and cellular disassociation). CD80 works in tandem with CD86 to prime T cells. CD80 plays a role in induction of innate immune responses by activating NF-κB-signaling pathway in macrophages. CD80 is thus regarded as promising therapeutic targets for autoimmune diseases and various carcinomas.

Recent Advances

 
Drug Development Progress
  • English Name:

    Cluster of differentiation 80

  • Category:

  • Approved Drugs:

    2 Details

  • Drugs in Clinical Trials:

    10 Details

  • Highest Development Stage:

    Approved

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background